Cargando…
Proteomic analysis of inhibitor of apoptosis protein-like protein-2 on breast cancer cell proliferation
Although inhibitor of apoptosis protein-like protein-2 (ILP-2) is considered to be a novel enhancer of breast cancer proliferation, its underlying mechanism of action remains unknown. Therefore, the present study aimed to investigate the expression profile of ILP-2-related proteins in MCF-7 cells to...
Autores principales: | Xiang, Siqi, Zhu, Lin, Zhang, Zhiliang, Wang, Siyuan, Cui, Ruxia, Xiang, Mingjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809121/ https://www.ncbi.nlm.nih.gov/pubmed/35039877 http://dx.doi.org/10.3892/mmr.2022.12605 |
Ejemplares similares
-
Inhibitor of apoptosis protein-like protein-2: A novel growth accelerator for breast cancer cells
por: Zhu, Lin, et al.
Publicado: (2018) -
Inhibitor of Apoptosis Protein-Like Protein-2 as a Novel Serological Biomarker for Breast Cancer
por: Xiang, Mingjun, et al.
Publicado: (2012) -
ILP-2: A New Bane and Therapeutic Target for Human Cancers
por: Zhang, Zhiliang, et al.
Publicado: (2022) -
Inhibitor of apoptosis proteins in breast cancer
por: Foster, FM, et al.
Publicado: (2006) -
Inhibitor of apoptosis proteins as a therapeutic target in breast cancer
por: Foster, FM, et al.
Publicado: (2008)